OliX Pharmaceuticals

#Oligonucleotides #RNAi #siRNA #cp-asiRNA #GalNAc #AMD #GA #NASH #HBV #Hypertrophic #Scar #Retinitis #Pigmentosa #KOSDAQ #226950

[OliX Pharmaceuticals @OliXPharma]

We are very excited that we have received positive headline results of a phase 2a trial in OLX10010, the treatment of hypertrophic scar!

Learn more: https://t.co/Ucm9pc7AFY

[OliX Pharmaceuticals @OliXPharma]

Our research director and business development team will be in San Francisco at JPM Healthcare Conference next week! Looking forward to catching up with partners, investors, and colleagues there.

Wishing you all a happy and successful new year! 😊

[OliX Pharmaceuticals @OliXPharma]

We are thrilled to announce that OliX has recently published preclinical research demonstrating OLX104C's potential as an effective treatment for hair loss. Check us out in Bloomberg for more details on the publication!

https://t.co/RjmEaZ2fG4

[OliX Pharmaceuticals @OliXPharma]

Exciting news! OliX recently announced positive preclinical data in NASH non-human primate models. Check out our press release for more information on this exciting data!

More info:https://t.co/FOFUig9mqb

[OliX Pharmaceuticals @OliXPharma]

OliX is attending BIO-Europe 2022, held in Leipzig from October 24-26, where we will participate in one-on-one partnering meetings and share the R&D status of our current treatment pipelines. We look forward to meeting you all! #bioeurope2022
Learn more: https://t.co/Vrv2ZLn40E

[OliX Pharmaceuticals @OliXPharma]

We are thrilled to announce the US FDA's clearance of the IND application for OLX301A, our first-in-class ophthalmic program.

Read more: https://t.co/eCCxYVYT4v

#AMD #RNAi #OLX301A #OLX10212 #GA #neovascularAMD #FDAclearance

[BIDMC_GI @BIDMC_GI]

Congratulations to Drs. Gordon Jiang and Yury Popov who have been selected to receive a @MALifeSciences Novel Theraputics Delivery Award to fund their exciting research in partnership with Olix Pharmaceuticals on, “Hepatocyte-specific delivery of RNA therapy for liver failure.”

[OliX Pharmaceuticals @OliXPharma]

We are participating in one-on-one partnering meetings at BIO-Europe Spring®, being held digitally from March 28-31, 2022. See you there!

#bioeuropespring #BIOEUROPE #GalNAc #RNAi

Read more: https://t.co/aSg8EnF277

[OliX Pharmaceuticals @OliXPharma]

We are incredibly pleased to announce that we've entered into a global license and collaboration agreement with @hansoh to advance the development of #RNAi therapeutics for various diseases.
#GalNAc
Read more: https://t.co/TTTi7AzvvH

[OliX Pharmaceuticals @OliXPharma]

We will be presenting 4 posters at the 2021 @OTSociety Virtual Conference across our pipeline. Proud to be their Gold sponsor since 2019!

Learn more: https://t.co/lfSfpMHQTp

#OTS2021 #GalNAc #goldsponsor

[OliX Pharmaceuticals @OliXPharma]

Our #hairloss program soon to be #patented! #OLX104C

Learn more: https://t.co/Z71VhBYPjh

[OliX Pharmaceuticals @OliXPharma]

Excited to share our #NASH data for the first time! In the study, mice receiving OLX702A showed more than 10% weight loss and restored fatty liver tissues almost to a normal level. Definitely moving forward with our #GalNAc-asiRNA platform!

Learn more: https://t.co/nJdlmPDBgm

[OliX Pharmaceuticals @OliXPharma]

OliX and @LGCBiosearch collaborate again for #hairloss program.

“We are pleased to expand upon our long-standing relationship with LGC... it will enable us to accelerate the production of OLX104C as we initiate clinical trials”

Learn more: https://t.co/hFXl5Su3oJ

[OliX Pharmaceuticals @OliXPharma]

Great news for our subsidiary, mCureX!
#mrnavaccines #mRNA #COVID19

Learn more: https://t.co/MmwsTiwyB8

[OliX Pharmaceuticals @OliXPharma]

We are moving forward with our #patented #improved intracellular delivery platform technology. Ready to accelerate the pace of preclinical and clinical development across our programs!

Learn more: https://t.co/9BGAjVYjX2

[OliX Pharmaceuticals @OliXPharma]

Excited to see what lies ahead with our collaboration with PCI Biotech Holding ASA!

#asiRNA #fimaNAc #DDS #Hairloss

Learn more:
https://t.co/gqUMZv2L3B

[OliX Pharmaceuticals @OliXPharma]

Many thanks to @BioCentury for highlighting our work to advance #RNAitherapeutics and #mRNA vaccines through our mCureX subsidiary.

Read more here: https://t.co/8WXyr3xv7a

[OliX Pharmaceuticals @OliXPharma]

For those of you who are suffering from #HairLoss, we have fascinating news to share. OLX104C preclinical study results look very promising!
#alopecia #HairLoss #baldness

Learn more: https://t.co/auyTR5gpWF

[OliX Pharmaceuticals @OliXPharma]

We recently launched new subsidiary #mCureX Therapeutics to accelerate development of mRNA vaccines and therapeutics! Very excited to be part of #mRNA #vaccine race for animal & human diseases!

Learn more:
https://t.co/RhdBAsbLCr

[OliX Pharmaceuticals @OliXPharma]

OliX will be presenting at 2021 ICR Conference under Therapeutics-Public track today. We are excited to discuss our #GalNAc and #asiRNA platforms! Be there to meet the amazing @OliXceo, DK!

Learn more:
https://t.co/AmF4OM1H7M